Pharmanutra S.p.A. (BIT:PHN)
79.10
+0.40 (0.51%)
Apr 28, 2026, 5:35 PM CET
Pharmanutra Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 757 | 521 | 523 | 542 | 601 | 730 | Upgrade
|
| Market Cap Growth | 62.45% | -0.23% | -3.62% | -9.76% | -17.67% | 100.53% | Upgrade
|
| Enterprise Value | 747 | 520 | 523 | 552 | 595 | 710 | Upgrade
|
| Last Close Price | 79.10 | 54.30 | 53.41 | 54.47 | 59.24 | 70.91 | Upgrade
|
| PE Ratio | 37.91 | 26.07 | 31.47 | 42.26 | 39.94 | 53.01 | Upgrade
|
| Forward PE | 31.13 | 23.47 | 25.25 | 32.36 | 38.79 | 53.54 | Upgrade
|
| PS Ratio | 5.73 | 3.95 | 4.50 | 5.39 | 7.24 | 10.71 | Upgrade
|
| PB Ratio | 10.63 | 7.32 | 8.41 | 9.97 | 11.80 | 16.19 | Upgrade
|
| P/TBV Ratio | 15.19 | 10.46 | 12.79 | 16.38 | 19.87 | 18.30 | Upgrade
|
| P/FCF Ratio | 46.10 | 31.74 | 32.32 | - | - | 47.32 | Upgrade
|
| P/OCF Ratio | 38.72 | 26.66 | 25.59 | 44.85 | 34.41 | 35.76 | Upgrade
|
| PEG Ratio | - | 1.77 | 1.77 | 1.77 | 1.77 | 1.77 | Upgrade
|
| EV/Sales Ratio | 5.65 | 3.94 | 4.50 | 5.49 | 7.16 | 10.41 | Upgrade
|
| EV/EBITDA Ratio | 23.14 | 16.36 | 16.93 | 21.72 | 24.56 | 36.76 | Upgrade
|
| EV/EBIT Ratio | 25.68 | 17.88 | 19.11 | 24.00 | 25.78 | 38.78 | Upgrade
|
| EV/FCF Ratio | 45.49 | 31.68 | 32.33 | - | - | 46.00 | Upgrade
|
| Debt / Equity Ratio | 0.29 | 0.29 | 0.39 | 0.52 | 0.35 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | 0.64 | 0.64 | 0.79 | 1.10 | 0.73 | 0.33 | Upgrade
|
| Debt / FCF Ratio | 1.25 | 1.25 | 1.50 | - | - | 0.41 | Upgrade
|
| Net Debt / Equity Ratio | -0.14 | -0.14 | -0.08 | 0.05 | -0.18 | -0.61 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.32 | -0.32 | -0.15 | 0.11 | -0.38 | -1.43 | Upgrade
|
| Net Debt / FCF Ratio | -0.61 | -0.61 | -0.29 | -2.50 | 1.05 | -1.79 | Upgrade
|
| Asset Turnover | 1.09 | 1.09 | 1.01 | 0.95 | 0.97 | 1.11 | Upgrade
|
| Inventory Turnover | 8.28 | 8.28 | 7.53 | 7.76 | 10.13 | 15.13 | Upgrade
|
| Quick Ratio | 1.86 | 1.86 | 1.94 | 1.70 | 1.96 | 3.08 | Upgrade
|
| Current Ratio | 2.35 | 2.35 | 2.38 | 2.12 | 2.28 | 3.32 | Upgrade
|
| Return on Equity (ROE) | 29.87% | 29.87% | 28.40% | 24.36% | 31.34% | 33.26% | Upgrade
|
| Return on Assets (ROA) | 14.99% | 14.99% | 14.88% | 13.54% | 16.82% | 18.58% | Upgrade
|
| Return on Invested Capital (ROIC) | 30.42% | 32.39% | 29.06% | 25.63% | 50.00% | 74.25% | Upgrade
|
| Return on Capital Employed (ROCE) | 30.90% | 30.90% | 30.40% | 27.20% | 31.00% | 33.50% | Upgrade
|
| Earnings Yield | 2.64% | 3.84% | 3.18% | 2.37% | 2.50% | 1.89% | Upgrade
|
| FCF Yield | 2.17% | 3.15% | 3.09% | -0.21% | -1.45% | 2.11% | Upgrade
|
| Dividend Yield | 1.52% | 2.21% | 1.87% | 1.56% | 1.35% | 1.00% | Upgrade
|
| Payout Ratio | 47.95% | 47.95% | 49.20% | 60.11% | 45.53% | 47.10% | Upgrade
|
| Buyback Yield / Dilution | 0.16% | 0.16% | 0.67% | 0.05% | 0.09% | - | Upgrade
|
| Total Shareholder Return | 1.69% | 2.37% | 2.54% | 1.61% | 1.44% | 1.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.